ProCE Banner Series

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

Gain expert insight on current best practices and emerging strategies for using BCMA-targeted therapies in relapsed/refractory multiple myeloma in these interactive, expert led 1-hour CME/CNE/CPE-certified workshops.

To Register:  Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  ACPE
  | AMA
  | ANCC
Credits Available

1.0

Who Should Attend

This program is intended for hematologists, oncologists, nurses, pharmacists, and other HCPs on the multidisciplinary team caring for patients with multiple myeloma.

All Events

Past Events

June

27

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

12:00 PM - 1:00 PM Eastern Time (ET)

Virtual

Private Event, Royal Oak, Michigan

July

11

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

6:00 PM - 7:00 PM Central Time (CT)

Virtual

CCO Simulcast | Host Group TX, San Antonio, Texas

July

25

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

11:30 AM - 12:30 PM Central Time (CT)

Virtual

Private Event | Virtual, Norman, Oklahoma

July

26

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

7:00 PM - 8:00 PM Eastern Time (ET)

In-person

Private Event | Host Group at Sevan, Oakland Gardens, New York

July

27

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

7:00 PM - 8:00 PM Pacific Time (PT)

In-person

Private Event | Host Group at HL Peninsula, Burlingame, California

August

09

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

12:00 PM - 1:00 PM Eastern Time (ET)

In-personVirtual

Private Event | Host Group Brooklyn, Brooklyn, New York

September

08

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

6:30 PM - 7:30 PM Pacific Time (PT)

In-person

Private Event | Host Group at Flemings, Los Angeles, California

September

15

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team [Open Registration]

7:00 AM - 8:00 AM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group NC, Hendersonville, North Carolina

September

16

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

9:30 AM - 10:30 AM Central Time (CT)

In-person

Private Event | Host Group at III, Houston, Texas

October

05

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

7:00 PM - 8:00 PM Central Time (CT)

In-person

Private Event | Host Group at Hampton Inn, Bemidji, Minnesota

October

12

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

6:00 PM - 7:00 PM Eastern Time (ET)

In-person

Private Event | Host Group Irish Eyes, Rehoboth, Delaware

October

17

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

6:30 PM - 7:30 PM Central Time (CT)

In-person

Private Event | Host Group IL, Crystal Lake, Illinois

October

21

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team

9:15 AM - 10:15 AM Pacific Time (PT)

In-person

Private Event | Host Group NV, Reno, Nevada

October

23

2023

Targeting BCMA for Relapsed/Refractory MM: Guidance for the Community Multidisciplinary Team [Open Registration]

11:30 AM - 12:30 PM Eastern Time (ET)

Virtual

CCO Simulcast | Host Group MD, Baltimore, Maryland

Topics

  • BCMA-Targeted Therapy in Multiple Myeloma: Advantages and Disadvantages
  • Understanding the Different Classes of BCMA-Targeted Therapies
  • Strategies to Mitigate BCMA Exhaustion and New Frontiers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge of, competence in, and performance in applying practice-changing clinical data and expert recommendations to integrate the use of BCMA-targeted agents for their patients with multiple myeloma. 

Target Audience
This program is intended for hematologists, oncologists, nurses, pharmacists, and other HCPs on the multidisciplinary team caring for patients with multiple myeloma. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Describe to patients the advantages and disadvantages for the 3 mechanisms of action for targeting BCMA
  • Identify patients with multiple myeloma who are likely to benefit from treatment with currently available BCMA-targeted therapy
  • Plan therapeutic strategies using BCMA-targeted therapies for patients with multiple myeloma, considering available efficacy, safety, and tolerability data along with guideline and expert recommendations
  • Identify mechanisms of resistance that can affect sequential use of BCMA-targeting agents
  • Monitor and mitigate potential adverse events from anti-BCMA therapy in patients with multiple myeloma, including but not limited to ocular toxicity, cytokine-release syndrome, and neurotoxicity

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-120-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC

Supported by educational grants from Bristol Myers Squibb and Regeneron Pharmaceuticals, Inc.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191